--- title: Montana’s new “right to try” law can’t come soon enough... description: Kris DeVault's three-year-old son Brody has creatine transporter deficiency, a rare genetic condition with no approved treatments. A French biotech, Ceres... canonical: https://daily.dev/posts/montana-s-new-right-to-try-law-can-t-come-soon-enough-for-some-6ls0awou8 twitter:card: summary_large_image twitter:site: @dailydotdev og:type: website og:site_name: daily.dev og:title: Montana’s new “right to try” law can’t come soon enough for some | daily.dev og:description: Kris DeVault's three-year-old son Brody has creatine transporter deficiency, a rare genetic condition with no approved treatments. A French biotech, Ceres... og:url: https://daily.dev/posts/montana-s-new-right-to-try-law-can-t-come-soon-enough-for-some-6ls0awou8 og:image: https://api.daily.dev/og/posts/6lS0AwoU8.png og:image:alt: Montana’s new “right to try” law can’t come soon enough for some og:image:width: 1200 og:image:height: 630 og:locale: en --- > ## Documentation Index > Fetch the complete documentation index at: https://daily.dev/llms.txt > Use this file to discover all available pages before exploring further. # Montana’s new “right to try” law can’t come soon enough for some **[MIT Technology Review](https://daily.dev/sources/technologyreview)** · 7 min read · 0 upvotes · 0 comments ## Summary Kris DeVault's three-year-old son Brody has creatine transporter deficiency, a rare genetic condition with no approved treatments. A French biotech, Ceres Brain Therapeutics, is developing a promising nasal-spray drug that has only completed a phase I trial in healthy adults. Montana's expanded 'right to try' law and its new Experimental Treatment Review Board could theoretically provide access, but the drug's manufacturer is hesitant due to potential FDA repercussions. DeVault is also exploring offshore clinics in Honduras. Scientists and bioethicists warn that phase I trials don't confirm safety or efficacy, while DeVault argues parents should have the right to make such decisions for their children. ## Full article daily.dev links to this article rather than hosting it. Read it at the original source: ## Similar posts on daily.dev - [Montana’s plan to become an experimental medical hub just pushed forward](https://daily.dev/posts/montana-s-plan-to-become-an-experimental-medical-hub-just-pushed-forward-8pdble29v) · MIT Technology Review · 0 upvotes · 0 comments - [The Download: Montana’s new experimental drug rules](https://daily.dev/posts/the-download-montana-s-new-experimental-drug-rules-nd9luaoak) · MIT Technology Review · 0 upvotes · 0 comments - [Tackling rare genetic disorders with patient-focused science](https://daily.dev/posts/tackling-rare-genetic-disorders-with-patient-focused-science-krlenyafo) · MIT News · 0 upvotes · 0 comments - [This company is developing gene therapies for muscle growth, erectile dysfunction, and “radical longevity”](https://daily.dev/posts/this-company-is-developing-gene-therapies-for-muscle-growth-erectile-dysfunction-and-radical-long-rbtk4d1cc) · MIT Technology Review · 0 upvotes · 0 comments - [Biotech Nephrogen combines AI and gene therapy to reverse kidney disease — check it out at TechCrunch Disrupt 2025](https://daily.dev/posts/biotech-nephrogen-combines-ai-and-gene-therapy-to-reverse-kidney-disease-check-it-out-at-techcrunc-h1whhgcuy) · TechCrunch · 0 upvotes · 0 comments --- Tags: [#biotech](https://daily.dev/tags/biotech) [View this post on daily.dev](https://daily.dev/posts/montana-s-new-right-to-try-law-can-t-come-soon-enough-for-some-6ls0awou8) ```json {"@context":"https://schema.org","@graph":[{"@type":"Organization","@id":"https://daily.dev/#organization","name":"daily.dev","url":"https://daily.dev","logo":{"@type":"ImageObject","url":"https://daily.dev/apple-touch-icon.png","width":180,"height":180},"sameAs":["https://twitter.com/dailydotdev","https://github.com/dailydotdev","https://www.linkedin.com/company/daily-dev-ltd"]},{"@type":"WebSite","@id":"https://daily.dev/#website","url":"https://daily.dev","name":"daily.dev","publisher":{"@id":"https://daily.dev/#organization"},"potentialAction":{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https://daily.dev/search?q={search_term_string}"},"query-input":"required name=search_term_string"}}]} {"@context":"https://schema.org","@type":"TechArticle","headline":"Montana’s new “right to try” law can’t come soon enough for some","url":"https://daily.dev/posts/montana-s-new-right-to-try-law-can-t-come-soon-enough-for-some-6ls0awou8","mainEntityOfPage":{"@type":"WebPage","@id":"https://daily.dev/posts/montana-s-new-right-to-try-law-can-t-come-soon-enough-for-some-6ls0awou8"},"datePublished":"2026-07-31T09:18:41.065Z","dateModified":"2026-07-31T09:23:08.489Z","description":"Kris DeVault's three-year-old son Brody has creatine transporter deficiency, a rare genetic condition with no approved treatments. A French biotech, Ceres...","image":"https://media.daily.dev/image/upload/f_auto,q_auto/v1/posts/6355ffeccdf6eb2005dfad3720b921e7?_a=AQAEuop","thumbnailUrl":"https://media.daily.dev/image/upload/f_auto,q_auto/v1/posts/6355ffeccdf6eb2005dfad3720b921e7?_a=AQAEuop","isAccessibleForFree":true,"articleSection":"MIT Technology Review","inLanguage":"en","publisher":{"@type":"Organization","name":"daily.dev","url":"https://daily.dev","logo":{"@type":"ImageObject","url":"https://daily.dev/apple-touch-icon.png","width":180,"height":180}},"author":{"@type":"Organization","name":"MIT Technology Review","logo":"https://media.daily.dev/image/upload/t_logo,f_auto/v1/logos/a8d03889722f4f22b3986e0b395ff076","url":"https://daily.dev/sources/technologyreview"},"commentCount":0,"discussionUrl":"https://daily.dev/posts/montana-s-new-right-to-try-law-can-t-come-soon-enough-for-some-6ls0awou8","interactionStatistic":[{"@type":"InteractionCounter","interactionType":{"@type":"LikeAction"},"userInteractionCount":0},{"@type":"InteractionCounter","interactionType":{"@type":"CommentAction"},"userInteractionCount":0}],"keywords":"biotech","timeRequired":"PT7M"} {"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://daily.dev"},{"@type":"ListItem","position":2,"name":"MIT Technology Review","item":"https://daily.dev/sources/technologyreview"},{"@type":"ListItem","position":3,"name":"Montana’s new “right to try” law can’t come soon enough for some"}]} ```